Category Specific RSS

TRU

TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint

TruScreen Group Limited (NZX/ASX:TRU), a medical device company focused on real-time cervical cancer screening, has raised NZ$2.35 million from a…

2 months ago

Truscreen expands market for real time digital diagnostic testing device

Ahh the pap smear. The daunting, uncomfortable and downright annoying process of having a cervical swab taken to be tested…

4 years ago